(Q46162572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Intranasal sufentanil for cancer-associated breakthrough pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

K Jackson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D Brumley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M Ashby

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

54-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19144765%20AND%20SRC:MED&resulttype=core&format=json

Breakthrough pain: definition, prevalence and characteristics

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

The history and development of the fentanyl series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

Comparison of intravenous and intranasal sufentanil absorption and sedation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

Pilot dose finding study of intranasal sufentanil for breakthrough and incident cancer-associated pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

Defining the clinically important difference in pain outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216308100249